Economic Insights and Deficits in European Biotechnology Patent Policy

Bernard Gilroy and Tobias Volpert

MPRA Paper from University Library of Munich, Germany

Abstract: The decisive statutory provision of the EU for patent protection of genetic engineering inventions is the so-called directive on biotechnological patents (DBP). Its objective is the encouragement of research and development in the genetic engineering sector. The following exposition shows that the DBP has two major flaws from the economist's point of view, under which particularly small and medium-sized enterprises, the driving force of this young line of business, suffer.

Keywords: Patent policy; biotechnology sector; Europe (search for similar items in EconPapers)
JEL-codes: L65 (search for similar items in EconPapers)
Date: 2002-05
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/22619/1/MPRA_paper_22619.pdf original version (application/pdf)

Related works:
Journal Article: Economic insights and deficits in European biotechnology patent policy (2002)
Working Paper: Economic Insights and Deficits in European Biotechnology Patent Policy (2002)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:22619

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().